For the year ending 2025-12-31, OSTX has $6,839,534 in assets. $11,864,460 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 269,830 | |||
| Prepaid expenses | 63,082 | |||
| Total current assets | 332,912 | |||
| Fixed assets (net) | 2,490 | |||
| Patent (net of amortization) | 6,504,132 | |||
| Total-long term assets | 6,506,622 | |||
| Total assets | 6,839,534 | |||
| Accounts payable | 9,936,387 | |||
| Accrued expenses | 1,415,002 | |||
| Accrued payroll and payroll taxes related party | 36,792 | |||
| Accrued payroll and payroll taxes | 1,279 | |||
| Preferred dividends payable | 375,000 | |||
| Total current liabilities | 11,764,460 | |||
| Tedco grant | 100,000 | |||
| Total long-term liabilities | 100,000 | |||
| Total liabilities | 11,864,460 | |||
| Series a convertible preferred stock, par value 0.001, 2,500,000 shares authorized 392,500 and 1,775,750 issued and outstanding, respectively | 1,070,705 | |||
| Total mezzanine equity | 1,070,705 | |||
| Common stock a, par value 0.001, 150,000,000 shares authorized 37,113,082 and 20,869,908 issued and outstanding, respectively | 37,116 | |||
| Additional paid-in capital | 61,053,472 | |||
| Accumulated deficit | -67,186,219 | |||
| Total stockholders deficit | -6,095,631 | |||
| Total liabilities, mezzanine equity and stockholders deficit | 6,839,534 | |||
OS Therapies Inc (OSTX)
OS Therapies Inc (OSTX)